Suppr超能文献

评估间质性膀胱炎/膀胱疼痛综合征患者(有或无Hunner溃疡)的症状严重程度和尿液细胞因子水平。

Evaluating symptom severity and urinary cytokine levels in interstitial cystitis/bladder pain syndrome patients, with and without Hunner's lesions.

作者信息

Zwaans Bernadette Mm, Mota Sabrina, Bartolone Sarah N, Ward Elijah P, Peters Kenneth M, Chancellor Michael B

机构信息

Oakland University William Beaumont School of Medicine Rochester, MI, USA.

Corewell Health William Beaumont University Hospital Royal Oak, MI, USA.

出版信息

Am J Clin Exp Urol. 2024 Apr 15;12(2):110-118. doi: 10.62347/BLED2401. eCollection 2024.

Abstract

PURPOSE

Interstitial cystitis/bladder pain syndrome (IC/BPS) is a condition characterized in part by urinary urgency, frequency, and pain. There is a strong interest in gathering more data to compare and assess the differences in characteristics based on the presence of Hunner's lesions in patients with IC/BPS.

MATERIALS AND METHODS

Using a nationwide crowdsource effort, we collected surveys and urine samples from patients with a history of IC/BPS. Participants completed the Interstitial Cystitis Symptom Index (ICSI) and Problem Index (ICPI), Overactive Bladder questionnaire (OABq SF), and pain scores. In addition, participants reported any co-morbidities and lifestyle modifications. Urinary cytokine levels were measured and compared to symptom severity.

RESULTS

491 participants enrolled: 119 with history of ulcerative Hunner's lesions (UIC), 372 reported no lesions (NHIC), and 2 unknowns. 96.3% were female, and prevalence of UIC was equal for both genders. Average age was higher for UIC vs. NHIC group (P = 0.011), as was the duration since diagnosis (P < 0.001). Symptom scores were elevated in UIC patients (P < 0.001). Both groups widely implemented lifestyle modifications, with dietary changes being most prevalent (70.1%), followed by prescription medication usage (63.1%). More UIC compared to NHIC participants experienced co-morbidities (P = 0.010). Urine samples were analyzed for GRO, IL-6, IL-8, and MCP-1. MCP-1 levels were significantly higher in UIC patients (P = 0.044). Weak positive correlation was found between cytokines and symptom scores.

CONCLUSIONS

Patients with UIC and NHIC from across the United States displayed distinct phenotypic and urine biological characteristics. These findings contribute to increased understanding of IC/BPS and may aid in improving our knowledge of the condition.

摘要

目的

间质性膀胱炎/膀胱疼痛综合征(IC/BPS)是一种部分特征为尿急、尿频和疼痛的病症。人们对收集更多数据以比较和评估基于IC/BPS患者中是否存在Hunner病变的特征差异有着浓厚兴趣。

材料与方法

通过全国范围的众包努力,我们收集了有IC/BPS病史患者的调查问卷和尿液样本。参与者完成了间质性膀胱炎症状指数(ICSI)和问题指数(ICPI)、膀胱过度活动症问卷(OABq SF)以及疼痛评分。此外,参与者报告了任何合并症和生活方式的改变。测量尿液细胞因子水平并与症状严重程度进行比较。

结果

491名参与者入组:119名有溃疡性Hunner病变病史(UIC),372名报告无病变(NHIC),2名情况不明。96.3%为女性,UIC在两性中的患病率相同。UIC组的平均年龄高于NHIC组(P = 0.011),诊断后的病程也是如此(P < 0.001)。UIC患者的症状评分升高(P < 0.001)。两组都广泛采取了生活方式的改变,饮食改变最为普遍(70.1%),其次是使用处方药(63.1%)。与NHIC参与者相比,更多的UIC参与者患有合并症(P = 0.010)。对尿液样本进行了GRO、IL-6、IL-8和MCP-1分析。UIC患者的MCP-1水平显著更高(P = 0.044)。细胞因子与症状评分之间存在弱正相关。

结论

来自美国各地的UIC和NHIC患者表现出不同的表型和尿液生物学特征。这些发现有助于加深对IC/BPS的理解,并可能有助于提高我们对该病症的认识。

相似文献

3
Does repeated hydrodistension with transurethral fulguration for interstitial cystitis with Hunner's lesion cause bladder contraction?
Arab J Urol. 2019 Apr 8;17(1):77-81. doi: 10.1080/2090598X.2019.1589753. eCollection 2019 Mar.
4
Unsupervised Machine Learning Reveals a Vulvodynia-Predominant Subtype in Bladder Pain Syndrome/Interstitial Cystitis.
Cureus. 2024 Jun 18;16(6):e62585. doi: 10.7759/cureus.62585. eCollection 2024 Jun.
5
Development of an interstitial cystitis risk score for bladder permeability.
PLoS One. 2017 Oct 31;12(10):e0185686. doi: 10.1371/journal.pone.0185686. eCollection 2017.
7
Multimodal therapies and strategies for the treatment of interstitial cystitis/bladder pain syndrome in Taiwan.
Low Urin Tract Symptoms. 2024 Jan;16(1):e12508. doi: 10.1111/luts.12508. Epub 2023 Nov 21.
10
Cystoscopic characteristic findings of interstitial cystitis and clinical implications.
Tzu Chi Med J. 2023 Aug 22;36(1):30-37. doi: 10.4103/tcmj.tcmj_172_23. eCollection 2024 Jan-Mar.

引用本文的文献

1
Clinical presentation of PD-1/PD-L1 immune checkpoint inhibitors induced cystitis.
Invest New Drugs. 2025 Jul 8. doi: 10.1007/s10637-025-01563-2.
2
The Pathomechanism and Current Treatments for Chronic Interstitial Cystitis and Bladder Pain Syndrome.
Biomedicines. 2024 Sep 10;12(9):2051. doi: 10.3390/biomedicines12092051.

本文引用的文献

2
Diagnosis and Treatment of Interstitial Cystitis/Bladder Pain Syndrome.
J Urol. 2022 Jul;208(1):34-42. doi: 10.1097/JU.0000000000002756. Epub 2022 May 10.
3
Using social media to crowdsource collection of urine samples during a national pandemic.
Int Urol Nephrol. 2022 Mar;54(3):493-498. doi: 10.1007/s11255-022-03108-5. Epub 2022 Jan 26.
4
Does irritable bowel syndrome increase the risk of interstitial cystitis/bladder pain syndrome? A cohort study of long term follow-up.
Int Urogynecol J. 2021 May;32(5):1307-1312. doi: 10.1007/s00192-021-04711-3. Epub 2021 Feb 23.
6
Interstitial cystitis/bladder pain syndrome: The evolving landscape, animal models and future perspectives.
Int J Urol. 2020 Jun;27(6):491-503. doi: 10.1111/iju.14229. Epub 2020 Apr 4.
7
Hunner Lesion Phenotype in Interstitial Cystitis/Bladder Pain Syndrome: A Systematic Review and Meta-Analysis.
J Urol. 2020 Sep;204(3):518-523. doi: 10.1097/JU.0000000000001031. Epub 2020 Mar 30.
8
Hunner lesion versus non-Hunner lesion interstitial cystitis/bladder pain syndrome.
Int J Urol. 2019 Jun;26 Suppl 1:26-34. doi: 10.1111/iju.13971.
9
Crowdsourcing Disease Biomarker Discovery Research: The IP4IC Study.
J Urol. 2018 May;199(5):1344-1350. doi: 10.1016/j.juro.2017.09.167. Epub 2017 Dec 7.
10
Development of an interstitial cystitis risk score for bladder permeability.
PLoS One. 2017 Oct 31;12(10):e0185686. doi: 10.1371/journal.pone.0185686. eCollection 2017.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验